LeonaBio (LONA) Operating Leases (2020 - 2026)
LeonaBio (LONA) posted quarterly Operating Leases of $213000.0 for Q1 2026, down 69.18% year-over-year from $691000.0 in Q1 2025, and down 36.98% quarter-over-quarter from $338000.0 in Q4 2025.
LeonaBio (LONA) Operating Leases (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has reported Operating Leases for 7 consecutive years, with $213000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Leases fell 69.18% year-over-year to $213000.0; the TTM figure through Mar 2026 stood at $213000.0 (down 69.18% YoY), while the FY2025 annual figure was $338000.0, down 57.91% from the prior year.
- Operating Leases fell to $213000.0 in Q1 2026 per LONA's latest filing, from $338000.0 in the prior quarter.
- Across five years, Operating Leases topped out at $1.8 million in Q2 2022 and bottomed at $213000.0 in Q1 2026.
- Historically, Operating Leases has averaged $1.1 million across 5 years, with a median of $1.1 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Leases decreased 1.52% — and 2026, when it tumbled 69.18%.
- LeonaBio's Operating Leases stood at $1.6 million in 2022, then fell by 23.22% to $1.2 million in 2023, then slumped by 34.02% to $803000.0 in 2024, then tumbled by 57.91% to $338000.0 in 2025, then tumbled by 36.98% to $213000.0 in 2026.
- Business Quant data shows LONA's Operating Leases at $213000.0 in Q1 2026, $338000.0 in Q4 2025, and $460000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | LeonaBio | 180.91 Mn | 129.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 213,000.00 |
| Dec 31, 2025 | 338,000.00 |
| Sep 30, 2025 | 460,000.00 |
| Jun 30, 2025 | 578,000.00 |
| Mar 31, 2025 | 691,000.00 |
| Dec 31, 2024 | 803,000.00 |
| Sep 30, 2024 | 912,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.41 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Sep 30, 2022 | 1.67 Mn |
| Jun 30, 2022 | 1.75 Mn |
| Mar 31, 2022 | 1.55 Mn |
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 1.71 Mn |
| Jun 30, 2021 | 1.78 Mn |